Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$1.23 - $2.25 $279,475 - $511,236
-227,216 Reduced 93.23%
16,500 $21,000
Q2 2023

Aug 09, 2023

SELL
$1.24 - $1.92 $89,546 - $138,652
-72,215 Reduced 22.86%
243,716 $419,000
Q1 2023

May 11, 2023

BUY
$1.34 - $2.62 $35,397 - $69,209
26,416 Added 9.12%
315,931 $461,000
Q4 2022

Feb 13, 2023

SELL
$1.44 - $3.44 $39,257 - $93,781
-27,262 Reduced 8.61%
289,515 $469,000
Q3 2022

Nov 14, 2022

BUY
$3.35 - $5.55 $113,263 - $187,645
33,810 Added 11.95%
316,777 $1.06 Million
Q2 2022

Aug 15, 2022

BUY
$3.12 - $7.52 $33,421 - $80,554
10,712 Added 3.93%
282,967 $1.03 Million
Q1 2022

May 13, 2022

SELL
$6.26 - $14.42 $87,032 - $200,481
-13,903 Reduced 4.86%
272,255 $1.97 Million
Q4 2021

Feb 11, 2022

BUY
$11.35 - $21.18 $63,253 - $118,036
5,573 Added 1.99%
286,158 $3.89 Million
Q3 2021

Nov 16, 2021

BUY
$18.17 - $24.7 $2.44 Million - $3.32 Million
134,534 Added 92.11%
280,585 $5.88 Million
Q2 2021

Aug 16, 2021

BUY
$20.08 - $29.02 $1.02 Million - $1.47 Million
50,690 Added 53.16%
146,051 $3.5 Million
Q1 2021

May 17, 2021

BUY
$27.0 - $32.48 $108,540 - $130,569
4,020 Added 4.4%
95,361 $2.79 Million
Q4 2020

Feb 16, 2021

BUY
$26.68 - $38.23 $2.44 Million - $3.49 Million
91,341 New
91,341 $2.73 Million

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $51.1M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.